9312350-008-gb-e_vidas_assay_solutions 2.pdf

4 pages
4 views

Please download to get full document.

View again

of 4
All materials on our website are shared by users. If you have any questions about copyright issues, please report us to resolve them. We are always happy to assist you.
Share
Description
Download 9312350-008-gb-e_vidas_assay_solutions 2.pdf
Tags
Transcript
  Assay Solutions VIDAS ®   -   PROTOCOLS - UNITS VIDAS ®   -   PARAMETERS  VIDAS ®   -   PROTOCOLS - UNITS VIDAS ®   -   PARAMETERS Compatible assays Protocols VIDAS ®  / mini VIDAS ®  / VIDAS 3 ® Parameter CodeSample volume TSH 200 µL T4 200 µL TSH3 200 µL FT3 100 µL FT4N 100 µL CORS 100 µL  ATPO 100 µL  ATG 100 µL T3 100 µL DIG 100 µL CKMB 250 µL TNHS 200 µL TNIU 200 µL PBN2 200 µL GAL3 200 µL PCT 200 µL MYO 150 µL DEX2 200 µL Parameter CodeSample volume  VWF 100 µL PC 100 µL HCG 100 µL FER  100 µL IgE 100 µL  AFP 100 µL E2II 200 µL  AMH  (a) 200 µL PRL 200 µL LH 200 µL FSH 200 µL PRG 200 µL CEAS 200 µL 199 200 µL 125 200 µL TPSA 200 µL FPSA 200 µL 153 100 µL GDH  (a) 300 µL CDAB  (a) 300 µL Parameter CodeSample volume HIV5 200 µL HIV6 200 µL P24 200 µL P24  (a) confirmation test 200 µL MSG 100 µL MPG 100 µL  VZG 100 µL RBM 100 µL TXC 125 µL TXGA  (b) 2 x 100 µL TXG 100 µL TXM 100 µL RBG 100 µL B2M 100 µL CMVG 100 µL CMVA 2 x 100 µL HPY  100 µL CMVM 100 µL HBCM 100 µL Parameter CodeSample volume HBS 150 µL  AHBS 200 µL HBS  (a) confirmation test 150 µL HBST 150 µL HCV  100 µL HBCT 150 µL HAVT 150 µL HBE 150 µL HBL 150 µL HBL  (a) confirmation test 150 µL HBET  (a) 150 µL HAVM 100 µL Parameter CodeSample volume LYM 100 µL LYG 100 µL LYGS 100 µL  VCAG 100 µL  VCAM  100 µL EBNA 100 µL  VITD 100 µL TES2 100 µL Units VIDAS ®  / mini VIDAS ®  / VIDAS 3 ® ParameterCodeProposed VIDAS UnitConversionFactors E2II pmol/Lnmol/Lpg/mL pg/mL x 3.67  pmol/Lpmol/L x 0.272  pg/mL FT4 pg/mLng/dLng/Lng/100 mLpmol/L pmol/L x 0.777  pg/mLpg/mL x 1.29  pmol/L T4 µg/Lµg/100 mLµg/dLnmol/L nmol/L x 0.777  µg/Lµg/L x 1.29  nmol/L FT3 pg/mLng/Lpmol/L pmol/L x 0.651  pg/mLpg/mL x 1.54  pmol/L T3 ng/mLµg/Lµg/100 mLµg/dLnmol/L nmol/L x 0.651  µg/Lµg/L x 1.54  nmol/L FER  µg/Lng/mL CORS nmol/Lµg/dLµg/Lng/mL nmol/L x 0.362  ng/mLng/mL x 2.76  nmol/L ParameterCodeProposed VIDAS UnitConversionFactors PRL µUI/mLµIU/mLng/mL 1 IRPng/mL 3 IS 1 ng 1 st  IRP = 32 µ UI1 ng 3 rd  IS = 21 µ UI1 ng/mL 3 rd  IS =1.524 ng/mL 1 st  IRP B2M µg/mLUI/mLIU/mLkUI/LkIU/Lmg/L mg/L x 14  UI/mLUI /mL x 0.071  mg/L  AFP µg/Lng/mLµg/mLIU/mLUI/mL ng/mL x 0.826  UI/mLUI /mL x 1.21  ng/mL TNHS ng/Lpg/mL TNIU ng/mLµg/L PBN2 pmol/Lpg/mL PCT µg/Lng/mL MYO µg/Lng/mL  VITD ng/mLnmol/L GAL3 ng/mL ParameterCodeProposed VIDAS UnitConversionFactors CEAS ng/mL ng/mL x 15.43  mUI/mL  AMH ** ng/mLpmol/Lng/dL pmol/L x 0.14  ng/mLng/mL x 7.14  pmol/L FSHLH IU/LmIU/mLUI/LmUI/mL HAVT IU/LmIU/mL UI/LmUI/mL HCG UI/LmIU/mLIU/LkUI/LkIU/LmUI/mL DIG nmol/Lµg/Lng/mL nmol/L x 0.781  ng/mLng/mL x 1.28  nmol/L PRG nmol/Lng/mL nmol/L x 0.3145  ng/mLng/mL x 3.1796  nmol/L TES2 nmol/Lng/mLng/dL nmol/L x 0.288  ng/mLng/mL x 3.47  nmol/L IgE UI/mLkIU/LIU/mLkUI/L ParameterCodeProposed VIDAS UnitConversionFactors ST kIU/LkUI/L TSH mUI/LµIU/mLmIU/LµUI/mL TSH3 µIU/mLµUI/mL HBST AHBS mIU/mLmUI/mL P24 pg/mL Ag P24pg/mL Ag VIH 1pg/mL of P24 = 3.65 pg/mL CMVG AU/mLUA/mL RBG UI/mLIU/mL TXG IU/mLUI/mL  vWF UI/mL PC IU/mL% DEX2 µg/mLng/mL  (FEU) (FEU) HBCM PEIU/mL Only parameters for which results can be expressed in different units are given in this table. (a) = After sample processing(b) = After dilution to obtain 15 IU/mL ➔➔➔➔➔➔➔➔➔➔➔➔➔➔➔➔➔➔➔➔➔➔➔➔➔➔➔➔➔➔➔➔➔➔ FEU: Fibrinogen Equivalent Unit ➔  Default Unit  arame er e erence o e amp e o umea rat on- ontroamp ere- rea menest va ate us ng est t me m nutes easuremen angeor nterpretat onest requency ..... 4  µL1 1 1 28 dayserum, Plasma  (Hep.)  (2) 0.05 - 200 ng/mL NT-proBNP24 PBN2200 µL1 S1 S2 S2 C1 C228 daysnoerum, Plasma  (Hep.) 15 - 25,000 pg/mL Troponin I Ultra44 I µL1 1 1 28 dayserum, Plasma  (Hep.) .1 - µgL Hs Troponin I  (C) 41 TNHS00 µl1 S1 S2 S2 C1 C228 daysnoSerum, Plasma Hep.) Galectin-341111 L µL1 1 128 daysSerum, Plasma  (Hep., EDTA) 3.3 - 100 ng/mL Myoglobin44 YO150 µL1 S1 C114 daysnoerum, Plasma  (Hep.) 15 - 1,000 µg/L CK-MB41 KMB µL1 S1 C114 daysSerum, Plasma  (Hep., EDTA) 0.8 - 300 ng/mL Digoxin DIG100 µL1 S1 S1 C114 daysnoSerum, Plasma  (Hep., EDTA) 0.2 - 5 ng/mL D-Dimer Exclusion TM  II4 DEX2200 µLS1 S1 C1 C228 daysnoPlasma  (Cit.) 45 - 10,000 ng/mL (FEU) Protein C11 PC1 µL1 S1 C114 daysPlasma  (Cit.) 1 - 1  vWF4 vWF100 µL1 S1 C114 daysnoPlasma  (Cit.) 1 - 1 HAV IgM0307 HAVM100 µLS1 S1 C1 C214 daysnoSerum, Plasma  (EDTA, Hep.) 0ualitative test: Negative, Positive or Equivocal  Anti-HAV Total1 H1 µL1 1 1 14 daysSerum, Plasma  (EDTA, Hep., Ct.) 1 - 4 mImL HBs Ag Ultra  (1) 1 HBSã HBL150 µLS1 S1 C1 C214 daysnoSerum, Plasma Hep.) 0 / 90ualitative test: Negative or Positive  Anti-HBsT II   1 H µL1 1 1 28 days  (2) erum, Plasma  (Hep.)  - mImL  Anti-HBc Total II14 H1 µL1 1 1 1 14 daysSerum, Plasma  (EDTA, Hep., Ct.) ualitative test: Negative, Positive or Equivocal c g 4 H1 µL1 1 1 14 dayserum, Plasma (EDTA, Hep., Ct.)  - 200 PEIU/mL HBe Ag HBE150 µLS1 S1 C1 C214 daysnoSerum, Plasma  (EDTA, Hep., Cit.) Qualitative test: Negative or Positive  Anti-HCV HCV100 µLS1 S1 C1 C228 daysnoerum, Plasma  (Hep.) 4Qualitative test: Negative or Positive HIV DUO Ultra44 HI µLS1 S1 S2 S2 C1 C2 C314 daysSerum, Plasma  (EDTA, Hep.)  (2) 1Ag and Ab qualitative test: Negative or Positive HIV DUO Quic447 HIV6200 µLS1 S1 C1 C2 C314 daysnoSerum, Plasma  (EDTA, Hep.)  2) Qualitative test: Negative or Positive HIV P24 II  (1) 117 P24200 µLS1 S1 C1 C214 daysnoSerum, Plasma (EDTA, Hep., Ox., Thrombin) 0 - 400 pg/mL o Ag P24 oxo g 1 µLS1 S1 C1 C214 dayserum  (3) 4ualitative test: Negative, Positive or Equivocal Toxo IgG II1 TXG100 µLS1 S1 C1 C214 daysnoSerum  3) , Plasma  (EDTA, Hep.) 40 - 300 IU/mL Toxo Competition11 TXC125 µLS1 S1 C1 C214 daysnoerum, Plasm  (EDTA, Hep.) 4Qualitative test: Negative or Positive oxo g  Aviity  (4) TXGA x 100 µLC1 C214 daysnoerum  3) , Plasma  (EDTA, Hep., Cit) 4Avidity index (AI)  An AI 0.3 is a strong indication f a prmary nfecton atng ac more than 4 months.An AI < tan 0.3 oes not enae a ecent infection to be differentiated from a former nfecton. Rub IgM14 RBM100 µLS1 S1 C1 C214 daysnoerumualitative test: Negative, Positive or Equivocal Rub IgG II1 RBG100 µLS1 S1 C1 C214 daysnoSerum, Plasma  (EDTA, Hep.) 40 - 400 IU/mL CMV IgM MVM1 µLS1 S1 C1 C214 dayserumualitative test: Negative, Positive or Equivocal CMV IgG0204 CMVG100 µLS1 S1 C1 C214 daysnoerum400 - 400 AU/mL CMV IgG  Aviity II417  x 1 µLH L14 dayserum4Avidity index (AI) An AI ≥  0.65 s a strong ncation   f a primary infection dating back more than 3 months.An AI < than 0.40 is a strong indi-cation of a primary infection dating back less than 3 months.An 0.40 < AI < 0.65 does not enable to distinguish a recent infection from a former infection. EBV VCA IgM7  VCAM100 µLS1 S1 S1 C1 C228 daysnoerum4ualitative test: Negative, Positive or Equivocal  g 1 µL1 1 1 1 28 dayserum4ualitative test: Negative, Positive or Equivocal g 1 µL1 1 1 1 28 dayserum4ualitative test: Negative, Positive or Equivocal     yme g1 L1 µLS1 S1 C1 C228 dayserum, Plasma  (Hep.) ualitative test: Negative, Positive or Equivocal Lyme IgG LYG100 µLS1 S1 C1 C228 daysnoerum, Plasma  (Hep.) , /CSFualitative test: Negative or Positive Measles IgG1 MSG100 µLS1 S1 C1 C214 days noerum4ualitative test: Negative, Positive or Equivocal Mumps IgG1 MPG100 µLS1 S1 C1 C214 daysnoerum4ualitative test: Negative, Positive or Equivocal  Varicella-Zoster IgG 0217  VZG100 µLS1 S1 C1 C214 daysnoerum40ualitative test: Negative, Positive or Equivocal H. pylori IgG1 H1 µL1 1 1 14 dayserum, Plasma  (EDTA) 4ualitative test: Negative, Positive or Equivocal C. iicile  1 H µL1 1 1 28 days  (2) toolQualitative test: Negative or Positive C. iicile Toxin A&B11 CDAB300 µLS1 S1 C1 C2 C314 daysyes  2) toolualitative test: Negative, Positive or Equivocal  AMH  (d) 41711 AMH200 µL1 S1 C128 daysnoerum, Plasma  (Lith., Hep.) 4.02 – 9 ng/mL Estraiol II41 II µL1 1 1 114 dayserum, Plasma  (Hep.) 9 - 3,000 pg/mL 47 H µL1 1 114 dayserum, Plasma  (Hep.) 4.1 - 11 mImL HCG4 HCG100 µL1 S1 C114 daysnoSerum, Plasma  (Hep., EDTA) 2 - 1,500 mIU/mL LH4 LH200 µL1 S1 C114 daysnoerum, Plasma  (Hep.) 40.1 - 100 mIU/mL Prolactin41 PRL200 µL1 S1 C114 daysnoerum, Plasma  (Hep.) 40.5 - 200 ng/mL rogesterone4  µL1 1 1 114 daysSerum, Plasma  (Hep., EDTA, Scone, Ge) 40.25 - 80 ng/mL estosterone 414 100 µl1 1 1 28 daysSerum, Plasma 40.05 to 13.50 ng/mL TSH4 TSH µL1 S1 C114 daysSerum, Plasma  (Hep., Beads, Gel) 4.05 - 60 µIU/mL TSH3441 TSH3200 µL1 S1 S2 S2 C1 C214 daysnoerum, Plasma Hep., Silicone, Gel) 0.005 - 100 µIU/mL 4 1 µL1 1 1 114 dayserum, Plasma  (Hep.) 4.7 - 45 pmol/L FT44 FT4N 100 µL1 S1 C114 daysnoserum, plasma  (Hep., Silicone, Gel) 41 - 100 pmol/mL 4 1 µL1 1 1 114 dayserum, Plasma  (Hep.) 40.4 - 9 nmol/L T444 T4200 µL1 S1 S1 C114 daysnoerum, Plasma  (Hep.) 4 - 320 nmol/L  Anti-TPO41 1 µL1 1 128 dayserum, Plasma (Hep., EDTA, Scone, Ge) . - 1, ImL  Anti-Tg4 ATG100 µL1 S1 C128 daysnoerum, Plasma6.4 - 800 IU/mL 41 1 µL1 1 114 daysSerum, Plasma Hep., EDTA) , Amniotic Fluid0.5 - 400 IU/mL CA 15-34 1100 µL1 S1 C114 daysnoerum, Plasma  (Hep, EDTA) 2 - 400 U/mL CA 19-9 TM 47 1 µL1 S1 C114 dayserum, Plasma  (Hep, EDTA) 3 - 500 U/mL  1 TM 4 1 µL1 1 114 dayserum, Plasma  (Hep, EDTA) 4 - 600 U/mL CEA S0453 EAS200 µL1 S1 C114 daysnoerum, Plasma  (Hep.) 00.5 - 200 ng/mL FPSA44 FPSA200 µL1 S1 C114 daysnoSerum, Plasma  (Hep., EDTA) 0.05 - 10 ng/mL TPSA4 TPSA200 µL1 S1 C114 daysnoSerum, Plasma  (Hep., EDTA) 0.07 - 100 ng/mL Total IgE41 IgE100 µL1 S1 C114 daysnoerum, Plasma Lith., Hep., EDTA) 0.5 - 1,000 kIU/L Cortisol S41 CORS100 µL1 S1 S1 C114 daysyes (urine)Serum, Plasma  (Hep., EDTA) , 24-hour Urine4 - 650 ng/mL Ferritin411 FER100 µL1 S1 C114 daysnoSerum, Plasma  (Hep., EDTA) 1.5 - 1,200 ng/mL 2 Microglobulin4 B2M100 µLS1 S1 C1 C214 daysyes (urine)erum, Plasma  (Hep., EDTA) , Urine40.004 - 4 mg/L 25 OH Vitamin D Total4 I1 µL1 1 128 dayserum, Plasma  (Lt., Hep.) 4.1 - 1 ngmL VIDAS ®  / mini VIDAS ®  / VIDAS ®  3: Parameters Range VENOUS THROMBO- EMBOLISM / COAGULATION CARDIAC  REPRODUCTION /  FERTILITY THYROID TUMOUR  MARKERS OTHERS  ALLERGY  HEPATITIS  HIV OTHER SEROLOGIES ToRC  ANTIGEN  DETECTION  BACTERIAL  INFECTION  (1) = Confirmation test available(2) = See package insert ã HBL = long protocol (c) = Some of these reagents have not yet obtained regulatory clearance in some countries. Please contact your local bioMérieux representative for further information and product availability.Some references may vary according the country. Please contact your local bioMérieux representative for further information and product availability.(d) = Not available in the following countries, regions and states: Armenia, Australia, Austria, Azerbaijan, Belarus, Belgium, Canada, Denmark, France, Germany, Hong-Kong, Ireland, Israel, Italy, Japan, Kazakhstan, Kyrgyzstan, Lichtenstein, Moldavia, New Zealand, Portugal, Russia, Spain, Switzerland, Tajikistan, The Netherlands, Turkey, Turkmenistan, United Kingdom. VIDAS -   PARAMETERS (3) = Inactivated or not 30 mins at 56°C(4) = Double strips    E   M   E   R   G   E   N   C   Y   I   M   M   U   N   O   C   H   E   M   I   S   T   R   Y   I   N   F   E   C   T   I   O   U   S   D   I   S   E   A   S   E   S  Instrument services ã Instant remote support serviceã Extensive network of local subsidiaries and distributors: skilled systems engineers and application specialists available wherever you are Certification support and integrated quality control ã VIDAS validation package for your instrument and methodologyã Support in obtaining ISO 15189 certification Online training ã Online training sessions complement VIDAS on-site serviceã Continually develop your lab’s skills and expertise A worldwide VIDAS community  ã The myvidas.com platform strengthens your expertise and makes the most of your VIDAS solutionã Share information and experiences with your VIDAS peers Benefit from bioMérieux’s experience with VIDAS ®  services, ensuring your lab’s continued development Scan this code to get access to myvidas.com  andthe constant updated information on VIDAS assay solutions.    1   2  -   1   6   /   9   3   1   2   3   5   0   /   0   0   8   /   G   B   /   E   /   D  o  c  u  m  e  n   t  a  n   d   /  o  r  p   i  c   t  u  r  e  s  n  o   t   l  e  g  a   l   l  y   b   i  n   d   i  n  g .   M  o   d   i   f   i  c  a   t   i  o  n  s   b  y   b   i  o   M   é  r   i  e  u  x  c  a  n   b  e  m  a   d  e  w   i   t   h  o  u   t  p  r   i  o  r  n  o   t   i  c  e   /   b   i  o   M   é  r   i  e  u  x ,   t   h  e   b   l  u  e   l  o  g  o ,   V   I   D   A   S  a  n   d  m   i  n   i   V   I   D   A   S  a  r  e  u  s  e   d  -  p  e  n   d   i  n  g  a  n   d   /  o  r  r  e  g   i  s   t  e  r  e   d   t  r  a   d  e  m  a  r   k  s   b  e   l  o  n  g   i  n  g   t  o   b   i  o   M   é  r   i  e  u  x ,  o  r  o  n  e  o   f   i   t  s  s  u   b  s   i   d   i  a  r   i  e  s ,  o  r  o  n  e  o   f   i   t  s  c  o  m  p  a  n   i  e  s   /   A  n  y  o   t   h  e  r  n  a  m  e  o  r   t  r  a   d  e  m  a  r   k   i  s   t   h  e  p  r  o  p  e  r   t  y  o   f   i   t  s  r  e  s  p  e  c   t   i  v  e  o  w  n  e  r   /   b   i  o   M   é  r   i  e  u  x   S .   A .   R   C   S   L  y  o  n   6   7   3   6   2   0   3   9   9   /   P   h  o   t  o  s  :   C .   G  a  n  e   t   /   P  r   i  n   t  e   d   i  n   F  r  a  n  c  e   /     T    H    E    R    A    C   o   n   s   e    i    l    /   R   C   S   L  y  o  n   B   3   9   8   1   6   0   2   4   2 bioMérieux S.A. 69280 Marcy l’Etoile France Tél. : +33  (0)4 78 87 20 00 Fax : +33  (0)4 78 87 20 90  www.biomerieux-diagnostics.com
Related Search
We Need Your Support
Thank you for visiting our website and your interest in our free products and services. We are nonprofit website to share and download documents. To the running of this website, we need your help to support us.

Thanks to everyone for your continued support.

No, Thanks
SAVE OUR EARTH

We need your sign to support Project to invent "SMART AND CONTROLLABLE REFLECTIVE BALLOONS" to cover the Sun and Save Our Earth.

More details...

Sign Now!

We are very appreciated for your Prompt Action!

x